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Renal cell carcinoma is the most common 
cancer involving the kidneys. It is reported to 
occur in 3% of all malignancies in adults and 
accounts for 90 - 95% of all cancers involving 
the kidneys. The peak age of diagnosis is 
between 50 and 70 years; in recent years the 
median age has been given as 64. There is 
also a slight predominance in males, with 
a ratio of 2:1.[1] Renal cell carcinoma has 
been attributed primarily to smoking, but 
other risk factors include conditions such 
as acquired cystic diseases of the kidneys, 
tuberous sclerosis and von Hippel Lindau 
(VHL) syndrome. Approximately 35% of 
patients with VHL disease develop clear 
renal cell carcinoma.[1]
Only 10% of patients present with the 
classic triad of flank pain, haematuria and 
a flank mass. The 5-year survival rate for 
stage 4 renal cell carcinoma is between 0% 
and 20%.[1]
We present a rare case of dual pathologies, 
renal cell carcinoma in the right kidney and 
angiomyolipoma in the left, which is still 
more unusual because the patient was a 
17-year-old girl. Verbal consent for the study 
and publication of material was obtained on 
initial presentation from the patient as well 
as the parent.
Case report
A 17-year-old girl of mixed race was referred 
to Potchefstroom Provincial Hospital, North 
West Province, South Africa, from the local 
clinic with what was thought to be spleno-
megaly. On arrival at the secondary hospital, 
the abdominal mass was confirmed and 
was reported probably to be of splenic 
origin. The history confirmed that the mass 
had been present for 5 months but had 
not caused problems until now. She had 
left-sided flank pain and dysuria, with no 
frank haematuria. Urine dipsticks showed 
microscopic haematuria (blood 4+, protein 
1+). She also complained of arthralgia, espe-
cially in the lower region of the back. There 
was intermittent nausea but rarely vomiting. 
She had developed a rash/freckles (pale 
reddish-brown soft small papules) on the 
face 8 months prior to initial presentation 
and was referred from the clinic with a 
query of angiofibroma (Fig. 1). Subsequent 
work-up for systemic lupus erythematosus 
was reported to be negative. The rash was 
reviewed and labelled as papulosa nigra, a 
normal variant of pigmented skin without 
any pathological features. No biopsy was 
done. The patient had no vaginal bleeding 
or discharge and reported normal bowel 
function; urine output was normal. She was 
not coughing and had no complaints of any 
neurological or cardiovascular symptoms, 
and reported no smoking or alcohol use. 
She reported not being sexually active, and 
a pregnancy test confirmed that she was 
not pregnant. Menstruation was reported as 
normal. She had no travel history, medical 
comorbidities or allergies. She was not using 
any form of contraception. There was a 
family history of malignancy in her brother, 
but the family did not know what type it 
was. She had no history of tuberculosis and 
had tested negative for HIV in the weeks 
preceding presentation.
Physical findings
The physical findings were unremarkable 
considering the under lying pathology. The 
patient was slightly underweight with a body 
mass index of 19 kg/m2. She was not pale 
or oedematous and no rash was seen. The 
findings on cardiovascular, respiratory and 
neurological examination were essentially 
normal apart from a slightly elevated blood 
pressure of 145/89 mmHg and a persis-
tent mild tachycardia of 106 bpm. She had 
a slight fever of 37.8°C and maintained 
saturation of 98% on room air. Abdominal 
examination revealed an abdominal mass 
on the left side measuring ~10 cm below 
the costal margin that moved inferiorly on 
inspiration. A notch was felt which at that 
time led the examiner to believe it was 
a massive spleen. The abdomen was soft 
and only mildly tender over the mass with 
no guarding or rebound tenderness. Bowel 
sounds were present and the liver was not 
palpable.
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Fig. 1. Possible angiofibromas indicative of tuber­
ous sclerosis.
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Side-room investigations showed microscopic haematuria (4+) 
and proteinuria (1+). The haemoglobin concentration was 11.5 g/
dL and a pregnancy test was negative. Blood samples were taken 
for spleno megaly work-up at the time and revealed nothing 
further to indicate the origin of the mass. Kidney function (urea 
2.4 mmol/L, creatinine 51 µmol/L, estimated glomerular filtration 
rate >60 mL/min/1.73 m2 and electrolyte levels were normal, as 
was liver function (alkaline phosphatase 96 U/L, gamma-glutamyl 
transpeptidase 16  U/L, alanine aminotransferase 10 U/L, aspartate 
aminotransferase 18 U/L, total bilirubin 4 µmol/L, albumin 42 g/L, 
total protein 85 g/L). A full blood count (white cell count 6.31 × 
109/L, haemoglobin 11.6 g/dL, platelets 264 × 109/L) was normal. A 
malaria screen, enzyme-linked immunosorbent assay for HIV and 
antinuclear antibody were negative. The C-reactive protein level 
was 32 mg/L. The erythrocyte sedimentation rate (ESR) was raised 
at 105 mm/h. The high ESR together with the presence of the mass 
alerted the clinician to serious pathology. The patient was sent for an 
urgent ultrasound scan, which revealed kidneys of normal size but 
with increased echogenicity. No hydronephrosis was observed, but a 
hypoechoic mass of 5 × 5 cm in the midpole of the right kidney and a 
tiny cyst on the lower pole of the left kidney were seen. The bladder, 
liver, gallbladder, spleen, pancreas and uterus were reported to be 
normal. The ovaries were not visualised owing to gas dilating the 
bowel. The patient was sent for an urgent computed tomography (CT) 
scan of the abdomen with contrast. The following day, the clinician 
was called to assess the CT scan together with the radiologist. The 
radiologist reported a hypodense mass with hyperdense vessels inside 
the lower part of the left kidney; it also consisted of fatty density 
and appeared hypervascularised after administration of contrast 
medium. On first glance, the mass measured 63 × 126 mm but on 
review it was 150 × 90 mm (Fig. 2). This mass was compressing the 
collecting system of the upper part of the left kidney as well as the 
aorta and some small bowel loops. Another enhancing solid mass 
was present in the middle part of the right kidney, measuring 51 × 
58 mm in diameter (Fig. 3). Neither ureter was dilated and there was 
good excretion of the contrast medium by both kidneys. No enlarged 
retroperitoneal lymph nodes were seen. There were some small 
sclerotic lesions in the thoracic and lumbosacral vertebral bodies and 
both iliac bones, suggestive of bone metastases.
The patient was referred to a tertiary setting for a nephrologist 
to perform a confirmative biopsy of the renal masses and provide 
further management.
Discussion
A search of the literature revealed articles describing these dual 
pathologies in one individual.[2-4] One of them had a unifying 
diagnosis of tuberous sclerosis.[3] These articles suggest that one 
should look for renal involvement in patients with tuberous 
sclerosis complex (TSC).[2-4] Could this patient have TSC, or could 
the angiomyolipoma be unusual renal metastases presenting 
radiologically as angiomyolipoma?[5] Could her freckles be mistaken 
for angiofibromas, which would support the diagnosis of tuberous 
sclerosis? These are important considerations in this case that 
may offer some treatment options. For example, she could receive 
treatment with everolimus (Afinitor), which is used for TSC and has 
been proven to have a 42% response rate in double-blind, placebo-
controlled phase III trial studies.[6,7]
Conclusion
This is an uncommon case of dual renal malignancies in a young girl, 
with a suspicion of TSC as the underlying cause.
The patient was referred to a tertiary setting for biopsy and further 
management. In the referral letter it was suggested that a diagnosis of 
TSC be considered.
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Fig. 2. Angiomyolipoma in the left kidney (arrow).
Fig. 3. Right kidney showing clear solid mass (black arrow) and left kidney 
deformed due to angiomyolipoma (white arrow).
